fullsizeoutput_b3b5.jpeg

Nathan Sigworth

Co-founder & CEO

Nathan was previously co-founder and CEO of PharmaSecure where he helped accelerate adoption of serialization as the standard in global pharmaceutical supply chain. Nathan is a graduate of Dartmouth College.

fullsizeoutput_ac54.jpeg

Richard Bergstrom

Co-founder & Customer Development

Richard was previously Director General of EFPIA and worked in regulatory affairs at Roche and Novartis. He has also served as Director of EU Regulatory Strategy at Roche and Director-General of LIF.

0.jpeg

Julia F. Bernstein

Director

Julia serves on the Board of Directors of PharmaCCX. She is currently COO at Tempest. She has been a commercial leader at Ginger.io, Beacon Health Options, Institute on Aging, and McKinsey. Julia is a graduate of Stanford GSB and Dartmouth College.


fullsizeoutput_ac38.jpeg

Peter Rice 

Chief Operating Officer

Prior to PharmaCCX Peter was Chief of Staff at Formlabs and held several roles at Alarm.com (ALRM) including Director of Program Management and rotations in Strategic Planning, Product Management, Supply Chain, and Finance. Peter is a graduate of Colby College and Thayer School of Engineering at Dartmouth College.

fullsizeoutput_ac49.jpeg

Armen Solakhyan

Chief Technology officer

Before joining PharmaCCX, Armen served in design and development roles at Farallon Capital Management, LifeYield and Charles River where he led the development of Fixed Income Execution Platform as part of the Charles River IMS.  He holds an M.S. in Computer Science from Armenian State Polytechnic Institute. 

Barath.jpg

Barath Shankar Subramanian

Director

Barath joined Accel in 2012 and serves on the PharmaCCX Board of Directors. He has been in the healthcare domain for over a decade, having previously been a senior consultant at Frost & Sullivan covering healthcare and life sciences. Barath has a bachelor’s degree in Pharmacy from BITS, Pilani and an MBA from Carnegie Mellon University.


fullsizeoutput_ac3c.jpeg

Marc Groz

Scientific Advisor

An inventor and a leading authority on risk and financial markets, Marc's research forms the foundation of our approach. Marc has served in mission-critical technology and investment modeling roles at Morgan Stanley, Van Eck Global, and Structured Portfolio Management.

Walter.jpg

Walter Hölzle

Senior Advisor

Former MD of Alcon and Warner-Lambert Switzerland, Walter leads VIPS (Swiss Pharma Association) as well as an organization that provides standards for unique identification of products and services.

fullsizeoutput_ac10.jpeg

Patrick Schneider

Pharma and Pricing advisor

Patrick was an ICU physician who left medical practice to join The Boston Consulting Group. He was recruited to build and lead the IMS Health consulting business in Switzerland and then launched his own practice consulting with the pharmaceutical industry on a variety of strategic areas, including pricing.


Photo+Alex.jpg

Alex Klippel

Full Stack Engineer

Alex has had multiple positions in the IT and engineering services industries in Germany, Spain, and the US. He served as a Software Engineer at StudentUniverse and as a Sr. Structural Engineer at Valladares Ingenieria. He holds an engineering degree from RWTH Aachen University in Germany and an M.S. in Real Estate Finance from University of Reading, UK.

Resized.jpg

Michelle Joyce

Executive Assistant and Office Manager

Michelle joins the PharmaCCX team after serving in similar roles at various startups, including Linkable Networks, XebiaLabs, Keurig, and iCorps Technologies. Michelle has a BA in Sociology from St. Anselm College.

Fredrik.jpg

FREDRIK MOEN

Customer Development Expert

Fredrik Moen is the Director for External relations at the Swedish Institute for Health Economics since February 2016. He is a professional with over 15 years experience working with health policy and European affairs, both in the public and private sectors. Between April 2017 and December 2017, he was serving as secretary to the Swedish National Commission on Funding, Pricing and Reimbursement of Pharmaceuticals (S2016:07).